These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9625372)

  • 21. Antiestrogenic compounds inhibit estrogen-induced expressions of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells.
    Fujimoto J; Hori M; Ichigo S; Hirose R; Tamaya T
    Gen Pharmacol; 1997 Feb; 28(2):215-9. PubMed ID: 9013197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.
    Yunokawa M; Yoshida H; Watanabe R; Noguchi E; Shimomura A; Shimoi T; Yonemori K; Shimizu C; Fujiwara Y; Tamura K
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):127-134. PubMed ID: 28540420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
    Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA
    Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Katsuki Y; Shibutani Y; Aoki D; Nozawa S
    Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of various steroids on platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA expression in uterine endometrial cancer cells.
    Aoki I; Fujimoto J; Tamaya T
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):217-22. PubMed ID: 12711006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ability of hydroxylated estrogens (2-OH-E2 and 4-OH-E2) to increase of SHBG gene, protein expression and intracellular levels in MCF-7 cells line.
    Gregoraszczuk EL; Ptak A; Wrobel A
    Endocr Regul; 2011 Jul; 45(3):125-30. PubMed ID: 21793624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of long-term treatment with MPA on the biological character of endometrial carcinoma Ishikawa cell].
    Zhao SJ; Chen XJ; Feng YJ
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2007 Apr; 40(2):103-12. PubMed ID: 17580663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiestrogenic compounds inhibit estrogen-induced expression of fibroblast growth factor family (FGF-1, 2, and 4) mRNA in well-differentiated endometrial cancer cells.
    Fujimoto J; Hori M; Ichigo S; Tamaya T
    Eur J Gynaecol Oncol; 1997; 18(6):497-501. PubMed ID: 9443020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor expression is not regulated by estradiol or medroxyprogesterone acetate in endometrial carcinoma.
    Kim YB; Berek JS; Martinez-Maza O; Satyaswaroop PG
    Gynecol Oncol; 1996 Apr; 61(1):97-100. PubMed ID: 8626126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of mechanism of medroxyprogesterone 17-acetate on the cancer stem cell-like properties of human endometrial cancer].
    Liu BJ; Li XP; Zhao LJ; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):772-7. PubMed ID: 24406136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts.
    Gong Y; Murphy LC; Murphy LJ
    J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):13-9. PubMed ID: 8049128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regulation of orphan receptor ERR alpha by estrogen and progesterone in endometrial carcinoma cell line].
    Gao M; Wei LH; Sun PM; Wang JL; Zhao D; Zhao C; Wang ZQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):281-3. PubMed ID: 15968320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
    Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
    Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans.
    Nader N; Raverot G; Emptoz-Bonneton A; Déchaud H; Bonnay M; Baudin E; Pugeat M
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2165-70. PubMed ID: 16551731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group.
    Thigpen JT; Brady MF; Alvarez RD; Adelson MD; Homesley HD; Manetta A; Soper JT; Given FT
    J Clin Oncol; 1999 Jun; 17(6):1736-44. PubMed ID: 10561210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells.
    Cao W; Gao W; Zheng P; Sun X; Wang L
    BMC Med Genomics; 2019 Nov; 12(1):163. PubMed ID: 31718641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma.
    Watanabe J; Watanabe K; Jobo T; Kamata Y; Kawaguchi M; Imai M; Okayasu I; Kuramoto H
    Int J Gynecol Cancer; 2006; 16 Suppl 1():452-7. PubMed ID: 16515645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of parathyroid hormone-related protein messenger RNA expression by medroxyprogesterone acetate in breast cancer tissues.
    Sugimoto T; Shiba E; Watanabe T; Takai S
    Breast Cancer Res Treat; 1999 Jul; 56(1):11-23. PubMed ID: 10517339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of insulin-like growth factors and their binding proteins in the estrogen responsive Ishikawa human endometrial cancer cell line.
    Hana V; Murphy LJ
    Endocrinology; 1994 Dec; 135(6):2511-6. PubMed ID: 7527333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.